NeuMoDx

QIAGEN is redefining automated clinical molecular testing with our exclusive partnership with NeuMoDx Molecular. The NeuMoDx platforms provide the industry’s first true continuous random-access solution and are scalable to meet the needs of the modern clinical laboratory. The unique integration of robotics with advanced microfluidics delivers industry-leading usability, enhanced performance, increased efficiency, and rapid turnaround by providing:

• Capacity to process over 300 samples in an eight-hour shift
• Ultra-fast insights with results available in around one hour for most tests
• True random access with continuous loading for CE-IVD and LDT tests in parallel
• Intuitive 3-step workflow with all room temperature stable reagents and consumables onboard